These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37640450)

  • 1. 2023 ACR/EULAR antiphospholipid syndrome classification criteria.
    Barbhaiya M; Zuily S; Naden R; Hendry A; Manneville F; Amigo MC; Amoura Z; Andrade D; Andreoli L; Artim-Esen B; Atsumi T; Avcin T; Belmont HM; Bertolaccini ML; Branch DW; Carvalheiras G; Casini A; Cervera R; Cohen H; Costedoat-Chalumeau N; Crowther M; de Jesús G; Delluc A; Desai S; Sancho M; Devreese KM; Diz-Kucukkaya R; Duarte-García A; Frances C; Garcia D; Gris JC; Jordan N; Leaf RK; Kello N; Knight JS; Laskin C; Lee AI; Legault K; Levine SR; Levy RA; Limper M; Lockshin MD; Mayer-Pickel K; Musial J; Meroni PL; Orsolini G; Ortel TL; Pengo V; Petri M; Pons-Estel G; Gomez-Puerta JA; Raimboug Q; Roubey R; Sanna G; Seshan SV; Sciascia S; Tektonidou MG; Tincani A; Wahl D; Willis R; Yelnik C; Zuily C; Guillemin F; Costenbader K; Erkan D;
    Ann Rheum Dis; 2023 Oct; 82(10):1258-1270. PubMed ID: 37640450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria.
    Barbhaiya M; Zuily S; Naden R; Hendry A; Manneville F; Amigo MC; Amoura Z; Andrade D; Andreoli L; Artim-Esen B; Atsumi T; Avcin T; Belmont HM; Bertolaccini ML; Branch DW; Carvalheiras G; Casini A; Cervera R; Cohen H; Costedoat-Chalumeau N; Crowther M; de Jesus G; Delluc A; Desai S; De Sancho M; Devreese KM; Diz-Kucukkaya R; Duarte-Garcia A; Frances C; Garcia D; Gris JC; Jordan N; Leaf RK; Kello N; Knight JS; Laskin C; Lee AI; Legault K; Levine SR; Levy RA; Limper M; Lockshin MD; Mayer-Pickel K; Musial J; Meroni PL; Orsolini G; Ortel TL; Pengo V; Petri M; Pons-Estel G; Gomez-Puerta JA; Raimboug Q; Roubey R; Sanna G; Seshan SV; Sciascia S; Tektonidou MG; Tincani A; Wahl D; Willis R; Yelnik C; Zuily C; Guillemin F; Costenbader K; Erkan D;
    Arthritis Rheumatol; 2023 Oct; 75(10):1687-1702. PubMed ID: 37635643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus.
    Aringer M; Costenbader K; Daikh D; Brinks R; Mosca M; Ramsey-Goldman R; Smolen JS; Wofsy D; Boumpas DT; Kamen DL; Jayne D; Cervera R; Costedoat-Chalumeau N; Diamond B; Gladman DD; Hahn B; Hiepe F; Jacobsen S; Khanna D; Lerstrøm K; Massarotti E; McCune J; Ruiz-Irastorza G; Sanchez-Guerrero J; Schneider M; Urowitz M; Bertsias G; Hoyer BF; Leuchten N; Tani C; Tedeschi SK; Touma Z; Schmajuk G; Anic B; Assan F; Chan TM; Clarke AE; Crow MK; Czirják L; Doria A; Graninger W; Halda-Kiss B; Hasni S; Izmirly PM; Jung M; Kumánovics G; Mariette X; Padjen I; Pego-Reigosa JM; Romero-Diaz J; Rúa-Figueroa Fernández Í; Seror R; Stummvoll GH; Tanaka Y; Tektonidou MG; Vasconcelos C; Vital EM; Wallace DJ; Yavuz S; Meroni PL; Fritzler MJ; Naden R; Dörner T; Johnson SR
    Arthritis Rheumatol; 2019 Sep; 71(9):1400-1412. PubMed ID: 31385462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus.
    Aringer M; Costenbader K; Daikh D; Brinks R; Mosca M; Ramsey-Goldman R; Smolen JS; Wofsy D; Boumpas DT; Kamen DL; Jayne D; Cervera R; Costedoat-Chalumeau N; Diamond B; Gladman DD; Hahn B; Hiepe F; Jacobsen S; Khanna D; Lerstrøm K; Massarotti E; McCune J; Ruiz-Irastorza G; Sanchez-Guerrero J; Schneider M; Urowitz M; Bertsias G; Hoyer BF; Leuchten N; Tani C; Tedeschi SK; Touma Z; Schmajuk G; Anic B; Assan F; Chan TM; Clarke AE; Crow MK; Czirják L; Doria A; Graninger W; Halda-Kiss B; Hasni S; Izmirly PM; Jung M; Kumánovics G; Mariette X; Padjen I; Pego-Reigosa JM; Romero-Diaz J; Rúa-Figueroa Fernández Í; Seror R; Stummvoll GH; Tanaka Y; Tektonidou MG; Vasconcelos C; Vital EM; Wallace DJ; Yavuz S; Meroni PL; Fritzler MJ; Naden R; Dörner T; Johnson SR
    Ann Rheum Dis; 2019 Sep; 78(9):1151-1159. PubMed ID: 31383717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria.
    Barbhaiya M; Zuily S; Ahmadzadeh Y; Amigo MC; Avcin T; Bertolaccini ML; Branch DW; de Jesus G; Devreese KMJ; Frances C; Garcia D; Guillemin F; Levine SR; Levy RA; Lockshin MD; Ortel TL; Seshan SV; Tektonidou M; Wahl D; Willis R; Naden R; Costenbader K; Erkan D;
    Arthritis Care Res (Hoboken); 2021 Oct; 73(10):1490-1501. PubMed ID: 33253499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiphospholipid Syndrome: To Classify or Not to Classify?
    Erkan D
    Turk J Haematol; 2024 Mar; 41(1):37-40. PubMed ID: 38284227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study.
    Gkrouzman E; Willis R; Andrade D; Tektonidou MG; Pengo V; Ruiz-Irastorza G; Belmont HM; Fortin PR; Gerosa M; Signorelli F; Atsumi T; Branch DW; Nalli C; Rodriguez-Almaraz E; Petri MA; Cervera R; Knight JS; Efthymiou M; Cohen H; Bertolaccini ML; Erkan D; Roubey R;
    Lab Invest; 2023 Jun; 103(6):100147. PubMed ID: 37044248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-criteria autoantibodies in antiphospholipid syndrome may be associated with underlying disease activity.
    Akyüz Dağlı P; Erden A; Babaoğlu H; Karakaş Ö; Özdemir Ulusoy B; Konak HE; Armağan B; Erten Ş; Omma A
    Ir J Med Sci; 2024 Apr; 193(2):1099-1107. PubMed ID: 37737913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Performance validation of the 2023 American College of Rheumatology/European League Against Rheumatism antiphospholipid syndrome classification criteria in an antiphospholipid syndrome cohort.
    Zhao Y; Huang C; Zhou Y; Qi W; Cai B; Hu C; Song Y; Zhu T; Shi X; Liu X; Wang Q; Tian X; Zhao Y; Zeng X; Li M; Zhao J
    J Thromb Haemost; 2024 Jun; 22(6):1660-1674. PubMed ID: 38462219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Diagnostic Value of New Additional Antiphospholipid Antibodies in Antiphospholipid Syndrome.
    Khogeer H; Altahan S; Alrehaily A; Sheikh A; Awartani K; Al-Kaff M; Saleh S; Alzahrani H; Alfattani A; Owaidah T
    Ann Clin Lab Sci; 2021 Jul; 51(4):552-556. PubMed ID: 34452895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extra-criteria antiphospholipid antibodies in patients with small vessel brain lesions and clinical manifestations associated with antiphospholipid syndrome.
    Estévez MÁ; Lanio N; Molina Á; Jiménez-León MR; Picado MJ; Esteban E; Sánchez S; Pallarés L; Julià MR
    J Stroke Cerebrovasc Dis; 2023 May; 32(5):107034. PubMed ID: 36842350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiphospholipid Antibody Testing for Anti-cardiolipin and Anti-β2 Glycoprotein I Antibodies Using Chemiluminescence-Based Panels.
    Favaloro EJ; Mohammed S; Vong R; Pasalic L
    Methods Mol Biol; 2023; 2663():297-314. PubMed ID: 37204719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
    Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
    J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to Domain I β
    Reshetnyak TM; Cheldieva FA; Cherkasova MV; Glukhova SI; Lila AM; Nasonov EL
    Dokl Biochem Biophys; 2023 Aug; 511(1):219-226. PubMed ID: 37833609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
    Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S
    Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APhL antibody ELISA as an alternative to anticardiolipin test for the diagnosis of antiphospholipid syndrome.
    Suh-Lailam BB; Cromar A; Davis KW; Tebo AE
    Int J Clin Exp Pathol; 2012; 5(3):210-5. PubMed ID: 22558475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis.
    Kelchtermans H; Pelkmans L; de Laat B; Devreese KM
    J Thromb Haemost; 2016 Aug; 14(8):1530-48. PubMed ID: 27279342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of anti-domain 1-β2 glycoprotein I antibodies in the diagnosis and risk stratification of antiphospholipid syndrome.
    De Craemer AS; Musial J; Devreese KM
    J Thromb Haemost; 2016 Sep; 14(9):1779-87. PubMed ID: 27314634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The (non-)sense of detecting anti-cardiolipin and anti-β2glycoprotein I IgM antibodies in the antiphospholipid syndrome.
    Chayoua W; Kelchtermans H; Gris JC; Moore GW; Musiał J; Wahl D; de Groot PG; de Laat B; Devreese KMJ
    J Thromb Haemost; 2020 Jan; 18(1):169-179. PubMed ID: 31519058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.